Clinical Study
Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged ≥ 55 Years in the SEER-Medicare Population
Table 1
Patient demographics (
).
| | Age* | (55–94 years) |
| | Stage | | | II | 213 (55.3%) | | III | 163 (42.3%) | | IVA | 9 (2.3%) |
| | Year of diagnosis | | | 1998 | 43 (11.2%) | | 1999 | 54 (14.0%) | | 2000 | 87 (22.6%) | | 2001 | 107 (27.8%) | | 2002 | 94 (24.4%) |
| | Histology | | | Squamous | 289 (75.1%) | | Adenocarcinoma | 55 (14.3%) | | Adenosquamous | 13 (3.4%) | | Other | 28 (7.3%) |
| | Race | | | Caucasian | 237 (61.6%) | | African-American | 74 (19.2%) | | Asian | 34 (8.8%) | | Hispanic | 25 (6.5%) | | Other | 15 (3.9%) |
| | Location | | | Big metropolitan (≥250,000) | 235 (61.0%) | | Metropolitan (20,000 to 249,999) | 94 (24.4%) | | Urban (2,500–19,999, adjacent metropolitan area) | 17 (4.4%) | | Less urban (2,500–19,999, not adjacent metro area) | 32 (8.3%) | | Rural (<2,500) | 7 (1.8%) | | Socioeconomic status (median income per census tract)* | 44,540 1,125 |
| | Comorbidity index, Charlson | | | 0 | 274 (71.2%) | | 1 | 63 (16.4%) | | 2 | 28 (7.3%) | | 3+ | 20 (5.2%) |
|
|
*Mean ±Standard Error of Mean.
|
